NZ243586A - Decahydrobenzo[a]pyrrolo[2,3-e]quinolizene and decahydro-8h-isoquino[2,1-g][1,6]naphthyreidine derivatives and pharmaceutical compositions thereof - Google Patents

Decahydrobenzo[a]pyrrolo[2,3-e]quinolizene and decahydro-8h-isoquino[2,1-g][1,6]naphthyreidine derivatives and pharmaceutical compositions thereof

Info

Publication number
NZ243586A
NZ243586A NZ243586A NZ24358692A NZ243586A NZ 243586 A NZ243586 A NZ 243586A NZ 243586 A NZ243586 A NZ 243586A NZ 24358692 A NZ24358692 A NZ 24358692A NZ 243586 A NZ243586 A NZ 243586A
Authority
NZ
New Zealand
Prior art keywords
pyrrolo
llaa
naphthyridine
decahydro
decahydrobenzo
Prior art date
Application number
NZ243586A
Other languages
English (en)
Inventor
Robin Douglas Clark
Michael Spedding
William Salisbury Redfern
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NZ243586A publication Critical patent/NZ243586A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NZ243586A 1991-07-17 1992-07-16 Decahydrobenzo[a]pyrrolo[2,3-e]quinolizene and decahydro-8h-isoquino[2,1-g][1,6]naphthyreidine derivatives and pharmaceutical compositions thereof NZ243586A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73169191A 1991-07-17 1991-07-17

Publications (1)

Publication Number Publication Date
NZ243586A true NZ243586A (en) 1995-03-28

Family

ID=24940584

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ243586A NZ243586A (en) 1991-07-17 1992-07-16 Decahydrobenzo[a]pyrrolo[2,3-e]quinolizene and decahydro-8h-isoquino[2,1-g][1,6]naphthyreidine derivatives and pharmaceutical compositions thereof

Country Status (14)

Country Link
EP (1) EP0524004A1 (esLanguage)
JP (1) JPH0665242A (esLanguage)
KR (1) KR930002346A (esLanguage)
AU (1) AU655998B2 (esLanguage)
CA (1) CA2074038A1 (esLanguage)
FI (1) FI923267L (esLanguage)
HU (2) HUT61550A (esLanguage)
IE (1) IE922314A1 (esLanguage)
IL (1) IL102521A (esLanguage)
IT (1) IT1256880B (esLanguage)
NO (1) NO922812L (esLanguage)
NZ (1) NZ243586A (esLanguage)
TW (1) TW209219B (esLanguage)
ZA (1) ZA925324B (esLanguage)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0411509A (pt) 2003-06-20 2006-07-25 Hoffmann La Roche compostos, processo para a sua manufatura, composições farmacêuticas que compreendem os mesmos, método para tratamento e/ou profilaxia de enfermidades que estão associadas com dpp-iv e sua utilização
CN103387583B (zh) 2012-05-09 2018-04-13 中国科学院上海药物研究所 二芳基并[a,g]喹嗪类化合物、其制备方法、药物组合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791108A (en) * 1987-04-13 1988-12-13 Syntex (U.S.A.) Inc. Sulfonyl-decahydro-8H-isoquino[2,1-G][1,6]-naphthyridines and related compounds useful as α2 -blockers

Also Published As

Publication number Publication date
ITTO920606A0 (it) 1992-07-16
ZA925324B (en) 1994-07-17
ITTO920606A1 (it) 1994-01-16
HUT61550A (en) 1993-01-28
CA2074038A1 (en) 1993-01-18
FI923267A7 (fi) 1993-01-18
NO922812D0 (no) 1992-07-16
AU2031392A (en) 1993-01-21
AU655998B2 (en) 1995-01-19
FI923267L (fi) 1993-01-18
TW209219B (esLanguage) 1993-07-11
IE922314A1 (en) 1993-01-27
IL102521A (en) 1996-05-14
FI923267A0 (fi) 1992-07-16
KR930002346A (ko) 1993-02-23
HU9202333D0 (en) 1992-10-28
JPH0665242A (ja) 1994-03-08
NO922812L (no) 1993-01-18
IT1256880B (it) 1995-12-27
EP0524004A1 (en) 1993-01-20
HU210711A9 (en) 1995-06-28

Similar Documents

Publication Publication Date Title
US5011846A (en) Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
US4673680A (en) α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
EP0065864A1 (en) Anti-hypertensive 1-substituted spiro (piperidine-oxobenzoxazines)
NZ225421A (en) 8,9-annelated-1,2,3,4-tetrahydro-beta-carboline derivatives, preparations thereof and pharmaceutical compositions
EP0518767B1 (en) Derivatives of amide analogs of certain methano bridged quinolizines
IE83573B1 (en) Derivatives of amide analogs of certain methano bridged quinolizines
EP0104632A2 (en) 1'-(3-(1,2-Benzisoxazol-3-yl)propyl)spiro-(benzofuran-2-(3H),3' or 4'-piperidine or 3'-pyrrolidines), a process for their preparation and their use as medicaments
AU613610B2 (en) Sulfonyldecahydro-8h-isoquino-(2,1-g) (1,6)-naphthyridines, optical isomers thereof and related compounds
NZ243586A (en) Decahydrobenzo[a]pyrrolo[2,3-e]quinolizene and decahydro-8h-isoquino[2,1-g][1,6]naphthyreidine derivatives and pharmaceutical compositions thereof
US5229387A (en) Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo [2,3-e]quinolizine derivatives
EP0607163B1 (en) NEUROLEPTIC 2-SUBSTITUTED PERHYDRO-1-H-PYRIDO[1,2-a]PYRAZINES
EP0329932B1 (en) Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments
WO1995014469A1 (en) Novel spirocycles
US4886798A (en) Optical isomers of sulfonyldecahydro-8H-isoquino-(2,1-G)(1,6) naphthyridines and related compounds useful as α2 -blockers
US4956365A (en) Decahydro-8H-isoquino(2,1-g)(1,6)naphthyridine derivatives and related compounds
EP0253572A1 (en) Substituted hexahydro arylquinolizines
US4831035A (en) Substituted hexahydroarylquinolizines
EP0259092A1 (en) Substituted hexahydroarylquinolizines
HU208137B (en) Process for producing condensed diazepinone derivatives and pharmaceutical compositions comprising same
US4916223A (en) Substituted hexahydroarylquinolizines
EP0571822B1 (en) Diazabicycloalkene derivatives
JPH08325267A (ja) ジアザビシクロ［３．３．１］ノナン誘導体、その中間体及びその医薬用途